Patent · US Expired

Midecamycin biosynthetic genes

US7070980B2 · kind B2 · utility

2Cited by
1References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2002
Grant dateJul 4, 2006
Priority date
Expiry dateSep 13, 2022

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12P19/62
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides an isolated polypeptide comprising a nucleotide sequence encoding a protein which is involved in midecamycin biosynthesis, wherein the protein contains an amino acid sequence selected from SEQ ID NOs: 2 to 10, 13, 14, 16, 19, 20, 22 to 26, and 28 to 38 or a modified amino acid sequence of the amino acid sequence having one or more amino acid modifications without affecting activity of the protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.